Quantity is not enough: completeness of suspected adverse drug reaction reports in Spain—differences between regional pharmacovigilance centres and pharmaceutical industry

1. Fernandez-Fernandez, C.
2. Lázaro-Bengoa, E.
3. Fernández-Antón, E.
4. Quiroga-González, L.
5. Montero Corominas, D.